CHF and Arrhythmias Archives - Page 156 of 157 - MPR

CHF and Arrhythmias

Nexterone approved for arrhythmias

Prism Pharmaceuticals announced that Nexterone (amiodarone HCl) Premixed Injection has been approved by the FDA for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy.

PRADAXA (dabigatran etexilate) 75mg, 150mg capsules by Boehringer Ingelheim

Pradaxa approved for stroke risk reduction

Boehringer Ingelheim announced that the FDA has approved Pradaxa (dabigatran etexilate capsules), an oral direct thrombin inhibitor, to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).